A large number of studies have shown that aPL, including lupus anticoagulant (LA), anticardiolipin antibodies (aCL), and anti-β2-glycoprotein I antibodies (anti-β2GPI), is closely involved in the pathological mechanism of APS [7, 8]. This evidence concerns the gene FASLG and autoimmune polyendocrinopathy.